Quantcast
Channel: Onglyza Lawsuit 2015 » __EMOJI__
Browsing latest articles
Browse All 13 View Live

Onglyza Not Linked to Elevated Cancer Risk

Onglyza is not associated with an elevated cancer risk, according to the results of new analysis of data from the SAVOR-TIMI 53 clinical trial. Last year, findings from that same study prompted federal...

View Article



Onglyza Heart Failure Cases Detailed in FDA Adverse Event Reports

Just months after the U.S. Food & Drug Administration (FDA) convened an advisory panel meeting to discuss a possible link between Onglyza (saxagliptin) and heart failure, a new analysis indicates...

View Article

Onglyza Heart Failure Worries Could Raise Januvia Profile

Could recent concerns surrounding Onglyza and heart failure prove to be a positive for some other Type 2 diabetes drugs? That’s definitely a possibility in the case of Januvia, which recently passed...

View Article

Onglyza Dropped From Formulary Amid Heart Failure Concerns

A potential link between Onglyza and heart failure has prompted a major pharmacy benefits manager to remove the Type 2 diabetes drug from its 2016 formulary. The exclusion by Express Scripts will also...

View Article

Manufacturer Funded Study Disputes Onglyza Heart Failure Risk

Mere months after a panel of health experts called for new label warnings regarding a possible link between Onglyza and heart failure, the manufacturer of the Type 2 diabetes drug released new research...

View Article


New Onglyza Safety Concern: Severe Joint Pain

Just months after its a group of medical advisers recommended that an Onglyza heart failure warning be added to its label, the U.S. Food & Drug Administration (FDA) is warning about another...

View Article

Onglyza Side Effects: Bone Fracture Risk Dubbed “Neutral”

Patients who rely on Onglyza to control Type 2 diabetes have one less safety issue to worry about. According to a newly-released study, Onglyza neither increases nor decreases the risk for bone...

View Article

Onglyza and Heart Failure: Still No Word from the FDA

U.S. health regulators have yet to announce any label changes for Onglyza, a Type 2 diabetes medication that may be associated with an increased risk of heart failure. The U.S. Food & Drug...

View Article


Onglyza Combo Treatment Rejected by FDA

The U.S. Food & Drug Administration (FDA) has given the thumbs down to a combination Type 2 diabetes medication being developed by AstraZeneca that would combine the active ingredients found in...

View Article


Onglyza Lawsuit Alleges Wrongful Death From Heart Failure

A new Onglyza lawsuit claims that the Type 2 diabetes medication caused a Chicago woman’s wrongful death from heart failure. The complaint, which is currently pending in Cook County Circuit Court in...

View Article
Browsing latest articles
Browse All 13 View Live




Latest Images